Effects of free and liposomal amphotericin B and gramicidin S alone and in combination on potassium leakage from human erythrocytes and Candida albicans
- PMID: 2470332
- PMCID: PMC171447
- DOI: 10.1128/AAC.33.2.152
Effects of free and liposomal amphotericin B and gramicidin S alone and in combination on potassium leakage from human erythrocytes and Candida albicans
Abstract
We studied the toxic effects of amphotericin B and gramicidin S, alone and in combination, using free and liposome-encapsulated drugs. In vitro toxic effects of the drugs on human erythrocytes and Candida albicans were determined by measuring leakage of intracellular potassium ions (K+). Liposomal formulations of both drugs greatly reduced K+ leakage from human erythrocytes, whereas liposomal gramicidin S, but not liposomal amphotericin B, prevented K+ leakage from C. albicans. In both free and liposomal forms, the combinations of drugs produced decreased toxicity to erythrocytes compared with the drugs alone. This protective effect was more apparent with liposomal combinations than with free drug combinations. A significant increase in fungal cell toxicity was observed, however, when free and liposomal drug combinations were tested against C. albicans. The results suggest that optimal concentrations of liposomal drug combinations (amphotericin B and gramicidin S) may provide increased toxicity against fungal cells and simultaneously protect mammalian cells.
Similar articles
-
Synergistic antifungal activity and reduced toxicity of liposomal amphotericin B combined with gramicidin S or NF.Antimicrob Agents Chemother. 1987 Dec;31(12):1978-81. doi: 10.1128/AAC.31.12.1978. Antimicrob Agents Chemother. 1987. PMID: 2449867 Free PMC article.
-
Affinity of amphotericin B for phosphatidylcholine vesicles as a determinant of the in vitro cellular toxicity of liposomal preparations.Biochim Biophys Acta. 1990 Jan 15;1021(1):39-45. doi: 10.1016/0005-2736(90)90381-w. Biochim Biophys Acta. 1990. PMID: 2403812
-
Study of the effects of liposomal amphotericin B on Candida albicans, Cryptococcus neoformans, and erythrocytes by using small unilamellar vesicles prepared from saturated phospholipids.Antimicrob Agents Chemother. 1989 Mar;33(3):345-9. doi: 10.1128/AAC.33.3.345. Antimicrob Agents Chemother. 1989. PMID: 2658784 Free PMC article.
-
Toxicity, stability and pharmacokinetics of amphotericin B in immunomodulator tuftsin-bearing liposomes in a murine model.J Antimicrob Chemother. 2006 Jul;58(1):125-32. doi: 10.1093/jac/dkl177. Epub 2006 May 18. J Antimicrob Chemother. 2006. PMID: 16709592
-
Liposomal amphotericin B. Therapeutic use in the management of fungal infections and visceral leishmaniasis.Drugs. 1998 Apr;55(4):585-612. doi: 10.2165/00003495-199855040-00008. Drugs. 1998. PMID: 9561346 Review.
Cited by
-
Antifungal activity of local anesthetics against Candida species.Infect Dis Obstet Gynecol. 2000;8(3-4):124-37. doi: 10.1155/S1064744900000168. Infect Dis Obstet Gynecol. 2000. PMID: 10968594 Free PMC article.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical